Lv1
18 积分 2022-04-28 加入
Semisynthetic Maytansine Analogues for the Targeted Treatment of Cancer
2天前
已完结
IMGN853, a Folate Receptor-α (FRα)–Targeting Antibody–Drug Conjugate, Exhibits Potent Targeted Antitumor Activity against FRα-Expressing Tumors
2天前
已完结
Comprehensive assessments of pharmacokinetics and immunogenicity of farletuzumab ecteribulin, a novel antibody-drug conjugate against tumors expressing folate receptor α, in monkeys
21天前
已完结
Evaluation of in vitro/in vivo bystander effect and immunogenic cell death induction by MORAb-202 (farletuzumab ecteribulin)
29天前
已完结
Derivation of AZD5335, a novel FRα-targeted TOP1i-loaded ADC, for the treatment of FRα-expressing cancers
2个月前
已完结
Kinetic Characterization of Inhibition of Cathepsins L and S by Peptides With Anticancer Potential
3个月前
已完结
Dual-payload ADCs move into first oncology clinical trials
3个月前
已关闭
Design and Preclinical Evaluation of a Novel B7-H4–Directed Antibody–Drug Conjugate, AZD8205, Alone and in Combination with the PARP1-Selective Inhibitor AZD5305
4个月前
已完结
MORAb-003, a fully humanized monoclonal antibody against the folate receptor alpha, for the potential treatment of epithelial ovarian cancer
5个月前
已关闭
皖公网安备34019202002308
